 |
 |
||||||
 |
Testimonios de nuestros clientes |
Su pedido
$0.00 (0 artículos)
| |||||
Genérico Ribavirin - Rebetol
- FDA approved Tadalafil medication for the treatment of erectile dysfunction accompanied with primary and secondary symptoms of benign prostatic hyperplasia (BPH) in men above 45 years.
Considering the information of three randomized, multicenter, double, blind clinical studies and a retrospective analysis of the medical documentation, FDA approved on October 7, 2011 Tadalafil medication for the treatment of erectile dysfunction accompanied with primary and secondary symptoms of benign prostatic hyperplasia (BPH) in men above 45 years.
- The forming, development and monitoring of the pharmaceutical market in USA in September 2011
In spite of low rates and stagnation of industrial development, the pharmaceutical market shows a dynamical growth.
- Sildenafil citrate and pulmonary arterial hypertension
Pulmonary arterial hypertension Definition “pulmonary arterial hypertension” is related to a group of diseases characterized by: - Progressive increase in pulmonary vascular resistance; - Reduction in pulmonary bloodflow; - High pulmonary artery pressure; - Contractility of the heart right ventricle; - Right ventricular failure.
- Fruit and vegetables do not reduce overall cancer risk, review concludes
Eating lots of fruit and vegetables will do little to reduce your risk of developing cancer, according to a review of a decade of research involving more than a million people.
- Common painkillers could be linked to male reproductive disorder
The use of mild painkillers, such as paracetamol, in pregnancy – previously considered harmless to the baby in the womb – could be a major factor in the rise of male reproductive disorders, according to a study.
Nuestra página de facturación está certificada por:
- GS-7977 with interferon/ribavirin cures most treatment-naive hepatitis C ... - aidsmap
GS-7977 with interferon/ribavirin cures most treatment-naive hepatitis C .
- HCV Patients May Be Able to Delay Therapy - MedPage Today
HCV Patients May Be Able to Delay TherapyMedPage TodayThe addition of new protease inhibitors telaprevir (Incivek) and boceprevir (Victrelis) to previous standard therapy of interferon and ribavirin have significantly boosted sustained viral response for many patients, especially for blacks and Latinos, .
- Medivir: Interim Report, 1 January -- 31 March 2012 - MarketWatch (press release)
Medivir: Interim Report, 1 January -- 31 March 2012MarketWatch (press release)Apart from interferon and ribavirin-free combination trials on TMC435 in phase II, this collaboration now also covers a phase III program Medivir opened 2012 with continued stable sales of Rx pharmaceuticals.
- Twelve Weeks of GS-7977 Eliminates HCV as Well as 24 Weeks - Medscape
Twelve Weeks of GS-7977 Eliminates HCV as Well as 24 WeeksMedscapeMay 2, 2012 (Barcelona, Spain) — Twelve weeks of GS-7977 (Gilead Sciences) plus pegylated interferon (pegIFN) and ribavirin was as effective as 24 weeks of treatment in eliminating hepatitis C virus (HCV) genotype 1.
- Experts Discuss DAAs for Difficult-To-Treat Hep C Patients - Infectious Disease Special Edition
Infectious Disease Special EditionExperts Discuss DAAs for Difficult-To-Treat Hep C PatientsInfectious Disease Special EditionOverall, the new reports revealed the following: Cirrhotic patients who previously received the standard two-drug therapy and then received telaprevir in combination with pegylated interferon (Peg-IFN) and ribavirin had improved SVR compared with .
|
| Copyright © Canadian Pharmacy Online. Todos los derechos reservados. |